Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

ISAL 2019 | The importance of genetic profiling: NGS, MRD & beyond

Tariq Mughal • 25 Feb 2019
ISAL 2019
General

Speaking at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, Tariq Mughal, MD, MB, BS, MRCS, MRCP, FRCP, of Tufts University School of Medicine, Boston, MA, discusses the importance of genetic profiling in hematological malignancies, and his research into this area.

More from Tariq Mughal

4:23
Acute leukemias: the doubled-edged sword of genetic complexity
Tariq Mughal • 25 Feb 2019
4:15
Precision medicine in hematological oncology: development to the present day
Tariq Mughal • 25 Feb 2019

Related Videos

4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
1:56
Addressing access inequality in CAR-T therapies
Francesca Del Bufalo • 15 Apr 2024
1:34
The future role of AI models in hematology and the need for high-quality data sets
Thomas Coats • 29 Apr 2024
6:38
Key papers in cardio-oncology from 2023 of relevance to hematologists
Alexander Lyon • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals